About Nucana Plc - ADR (NCNA)
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatments for cancer patients using its ProTide technology. ProTide are designed to overcome cancer resistance mechanism and generate... Read more
- USD4.01
- USD4.13
- USD3.82
- USD23.75
- -47.40%
- --
- 36.46k
- 8M
- 3.40
- -83.00%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
